Mixed Lymphocyte Reaction (MLR) Assay

The Mixed Lymphocyte Reaction (MLR) Assay is a functional in vitro assay used to evaluate T cell alloreactivity by measuring the proliferation of responder T cells upon exposure to allogeneic antigen-presenting cells (APCs). This assay is widely employed in transplantation immunology, immune tolerance studies, and immunotherapeutic development to assess the strength of alloimmune responses.

Principle of MLR Assay

  • Responder T cells recognize alloantigens presented by stimulator antigen-presenting cells (APCs).

  • Stimulator cells express foreign MHC molecules, which act as alloantigens.

  • Responder T cells become activated upon recognition of foreign MHC molecules.

  • Activated T cells proliferate and upregulate activation markers (e.g., CD69, CD25).

  • T cell response is measured using various readouts:

  • Proliferation assays

    • Cytokine secretion (IFN-γ, IL-2) using ELISA or multiplex assays.

    • Flow cytometry for activation marker expression and proliferation assessment.

Model Description

Allogeneic stimulator cells (PBMC, DC etc) are co-cultured with responder T cells, resulting in T cell activation and proliferation.

Readouts

T cell activation by flow cytometry and T cell response by cytokine secretion (IFN-γ, IL-2, and TNF-α release).

Add-On Services

Evaluation of cytokine release, proteomics, and transcriptomics.

Key Components of MLR Assay

A. Responder Cells (T Cells):

  • Peripheral blood mononuclear cells (PBMCs) or purified CD4⁺/CD8⁺ T cells.

  • Recognize foreign MHC molecules and initiate an immune response.

B. Stimulator Cells (Antigen-Presenting Cells, APCs):

  • Can be PBMCs, dendritic cells, or B cells from a genetically different donor.

  • Provide alloantigens (foreign MHC molecules) for T cell activation.

  • In one-way MLR, stimulator cells are inactivated (irradiated or mitomycin C-treated)

     to prevent their proliferation.

C. Readouts for T Cell Activation and Proliferation:

  • T cell activation markers:

  • CD69 and CD25 expression measured by flow cytometry.

  • Cytokine secretion assays:

  • ELISA or multiplex assays to measure IFN-γ, IL-2, and TNF-α levels.